Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-6034 Eye Drops Dose-Response Study in Dry Eye Syndrome
KCT0000517Phase 2Completed
- Sponsor
- Dong-A Pharmaceutical
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of recoflavone in dry eye syndrome (DED), sponsored by Dong-A Pharmaceutical. Started Apr 2012; status: completed.
02
Drugs
recoflavone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on KCT0000517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000517.